These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2769934)

  • 1. [Studies of lomefloxacin in biliary tract infections].
    Ono Y; Kunii O
    Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].
    Ohmori H; Kumon H; Suzuki K; Kamidono S; Arakawa S; Ishigami J; Tanaka H; Amano M; Fujita Y; Kanemasa Y
    Jpn J Antibiot; 1989 Apr; 42(4):1025-50. PubMed ID: 2671424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial activities of norfloxacin against clinical isolates from ocular infections].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Aug; 48(8):1009-25. PubMed ID: 7474324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
    Durazo F; Resano F; Gonzalez MA
    Diagn Microbiol Infect Dis; 1990; 13(1):71-5. PubMed ID: 2331854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM; Müller S; Kipp J; Stille W
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
    Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
    Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
    Tanimura H; Aoki Y; Uesaka K; Kasano Y; Nakai T; Kitamura T; Mukaihara S; Tamura K; Yotsumoto F; Terao R
    Nihon Geka Hokan; 1988 Sep; 57(5):381-99. PubMed ID: 3251425
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
    Sonstein SA; Dahlgren J
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of clinical efficacy of lomefloxacin (LFLX, NY-198) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Lomefloxacin Research Group Enteritis].
    Aoki T; Shimizu N; Tomizawa I; Takizawa Y; Matsubara Y; Nitta Y; Sagara H; Seo T; Kanehisa N; Murata M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):606-22. PubMed ID: 2693542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial effects of lomefloxacin in vitro.
    Chambers ST; Peddie BA; Robson RA; Begg EJ; Boswell DR
    J Antimicrob Chemother; 1991 Apr; 27(4):481-9. PubMed ID: 1856127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
    Tozawa K; Washida H; Honma H; Kang K; Yamada Y
    Hinyokika Kiyo; 1993 Sep; 39(9):801-5. PubMed ID: 8213373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
    Torres JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.